Trial intelligence / Profile preview

Pre-operative chlorhexidine versus povidone-iodine skin antisepsis in non-implant vascular surgery

2013-004743-23Phase 4Terminated

Sponsor
Hull University Teaching Hospitals
Start
Nov 2013
Modality
Small Molecules
Countries
1
01

Overview

Phase 4, randomised, open-label trial of chlorhexidine and povidone-iodine in surgical site infection (SSI) (4 arms), sponsored by Hull University Teaching Hospitals. Primary endpoint: Occurrence of surgical site infection. Started Nov 2013; status: terminated.

02

Drugs

chlorhexidinepovidone-iodine
03

Conditions

surgical site infection (SSI)

Beyond the preview

Go deeper on 2013-004743-23.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on 2013-004743-23.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call